|
1
|
Thakar CV, Christianson A, Freyberg R,
Almenoff P and Render ML: Incidence and outcomes of acute kidney
injury in intensive care units: A Veterans administration study.
Crit Care Med. 37:2552–2558. 2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kim WY, Huh JW, Lim CM, Koh Y and Hong SB:
A comparison of acute kidney injury classifications in patients
with severe sepsis and septic shock. Am J Med Sci. 344:350–356.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Peng Q and Zhang L, Ai Y and Zhang L:
Epidemiology of acute kidney injury in intensive care septic
patients based on the KDIGO guidelines. Chin Med J (Eng).
127:1820–1826. 2014.PubMed/NCBI
|
|
4
|
Chen YJ, Gong CL and Tan F: Effects of
dexmedetomidine pretreatment on inflammatory factors and oxidative
stress in rats with sepsis-induced renal injury. J Southern Med
Univ. 35:1472–1475. 2015.
|
|
5
|
Engelmann B and Massberg S: Thrombosis as
an intravascular effector of innate immunity. Nat Rev Immunol.
13:34–45. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Schrier RW and Wang W: Acute renal failure
and sepsis. N Engl J Med. 35:159–169. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ergin B, Kapucu A, Demirci-Tansel C and
Ince C: The renal microcirculation in sepsis. Nephrol Dial
Transplantat. 30:169–177. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Evans RG, Ince C, Joles JA, Smith DW, May
CN, O'Connor PM and Gardiner BS: Haemodynamic influences on kidney
oxygenation: Clinical implications of integrative physiology. Clin
Exp Pharmacol Physiol. 40:106–122. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Levy MM, Fink MP, Marshall JC, Abraham E,
Angus D, Cook D, Cohen J, Opal SM, Vincent JL and Ramsay G:
SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS international
sepsis definitions conference. Crit Care Med. 31:250–1256.
2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yu LP: Mesh Meta-analysis of the
differences in the effects of different ADP receptor antagonists on
platelet function in patients with coronary heart disease.
Practical Drugs Clini, 2016.
|
|
11
|
Thomas MR and Storey RF: The role of
platelets in inflammation. Thromb Haemost. 114:449–458.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Woollard KJ and Chin-Dusting J: P-selectin
antagonism in inflammatory disease. Curr Pharm Des. 16:4113–4118.
2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang Y and Chai YF: Relationship of sepsis
severity and platelet change. Pract Clin Med (Jiangxi). 19:16–18.
2018.
|
|
14
|
Gu X, Fu X, Wang Y, Zhang W, Fan W, Jiang
Y, Hao G, Miao Q, Li Y and Zhi W: Comparison of ticagrelor and
high-dose clopidogrel on the platelet functions in patients with
inadequate response to clopidogrel. Am J Cardiovasc Dis. 7:1–8.
2017.PubMed/NCBI
|
|
15
|
Zhao W and Sun GZ: Conversion of dosage
between different kinds of experimental animals. Animal Husbandry
Veterinary Sci Techn Infor. 5:52–53. 2012.
|
|
16
|
Jin H, Zhang Y, Ding Q, Wang SS, Rastogi
P, Dai DF, Lu D, Purvis M, Cao C, Wang A, et al: Epithelial innate
immunity mediates tubular cell senescence after kidney injury. JCI
Insight. 4(e125490)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Singbartl K and Ley K: Leukocyte
recruitment and acute renal failure. J Mol Med (Berl). 82:91–101.
2004.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gu G, Gao F, Zhi Y and Yin ZX: Comparison
of methods of isolation, preparation and culture about rat kidney
cells. Wei Sheng Yan Jiu. 34:574–576. 2005.PubMed/NCBI(In Chinese).
|
|
19
|
Wasung ME, Chawla LS and Madero M:
Biomarkers of renal function, which and when? Clin Chim Acta.
438:350–357. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yip HK, Chen SS, Liu JS, Chang HW, Kao YF,
Lan MY, Chang YY, Lai SL, Chen WH and Chen MC: Serial changes in
platelet activation in patients after ischemic stroke: Role of
pharmacodynamic modulation. Stroke. 35:1683–1687. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mullane KM, Kraemer R and Smith B:
Myeloperoxidase activity as a quantitative assessment of neutrophil
infiltration into ischemie myocardium. J Pharmacol Methods.
14:157–167. 1985.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Meduri GU, Headley S, Kohler G, Stentz F,
Tolley E, Umberger R and Leeper K: Persistent elevation of
inflammatory cytokines predicts a poor outcome in ARDS: Plasma
IL-1beta and IL-6 levels are consistent and efficient predictors of
outcome over time. Chest. 107:1062–1073. 1995.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Husted S and Van Giezen JJ: Ticagrelor:
The first reversibly binding oral P2Y12 receptor antagonist.
Cardiovas Ther. 27:259–274. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cattaneo M, Schulz R and Nylander S:
Adenosine-mediated effects of ticagrelor: Evidence and potential
clinical relevance. J Am Coll Cardiol. 63:2503–2509.
2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fani F, Regolisti G, Delsante M,
Cantaluppi V, Castellano G, Gesualdo L, Villa G and Fiaccadori E:
Recent advances in the pathogenetic mechanisms of sepsis-associated
acute kidney injury. J Nephrol. 31:351–359. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Furie B, Furie BC and Flaumenhaft R: A
journey with platelet P-selectin: The molecular basis of granule
secretion, signalling and cell adhesion. Thromb Haemost.
86:214–221. 2001.PubMed/NCBI
|
|
27
|
Lerolle N, Nochy D, Guérot E, Bruneval P,
Fagon JY, Diehl JL and Hill G: Histopathology of septic shock
induced acute kidney injury: Apoptosis and leukocytic infiltration.
Intensive Care Med. 36:471–478. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chappell D, Heindl B, Jacob M, Annecke T,
Chen C, Rehm M, Conzen P and Becker BF: Sevoflurane reduces
leukocyte and platelet adhesion after ischemia-reperfusion by
protecting the endothelial glycocalyx. Anesthesiologists.
115:483–491. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jansen MP, Florquin S and Roelofs JJ: The
role of platelets in acute kidney injury. Nat Rev Nephrol.
14:457–471. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lukens JR, Gurung P, Vogel P, Johnson GR,
Carter RA, McGoldrick DJ, Bandi SR, Calabrese CR, Vande Walle L,
Lamkanfi M and Kanneganti TD: Dietary modulation of the microbiome
affects autoinflammatory disease. Nature. 516:246–249.
2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang TY and Zhang ZX: Progress in
treatment of diffuse intravascular coagulation. Chin Pediatric
Emergency Med. 15:405–407. 2008.
|
|
32
|
Sexton TR, Zhang G, Macaulay TE, Callahan
LA, Charnigo R, Vsevolozhskaya OA, Li Z and Smyth S: Ticagrelor
reduces thromboinflammatory markers in patients with pneumonia.
JACC Basic Transl Sci. 3:435–449. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Mariano F, Cantaluppi V, Stella M,
Romanazzi GM, Assenzio B, Cairo M, Biancone L, Triolo G, Ranieri VM
and Camussi G: Circulating plasma factors induce tubular and
glomerular alterations in septic burns patients. Crit Care.
12(R42)2008.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Li X, Li Y, Shen K, Li H and Bai J: The
protective effect of ticagrelor on renal function in a mouse model
of sepsis-induced acute kidney injury. Platelets. 30:199–205.
2019.PubMed/NCBI View Article : Google Scholar
|
